1. Home
  2. SLXN vs YJ Comparison

SLXN vs YJ Comparison

Compare SLXN & YJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLXN
  • YJ
  • Stock Information
  • Founded
  • SLXN 2008
  • YJ 2015
  • Country
  • SLXN Israel
  • YJ China
  • Employees
  • SLXN N/A
  • YJ N/A
  • Industry
  • SLXN
  • YJ Other Specialty Stores
  • Sector
  • SLXN
  • YJ Consumer Discretionary
  • Exchange
  • SLXN NYSE
  • YJ Nasdaq
  • Market Cap
  • SLXN 7.3M
  • YJ 10.1M
  • IPO Year
  • SLXN N/A
  • YJ 2019
  • Fundamental
  • Price
  • SLXN $0.80
  • YJ $1.89
  • Analyst Decision
  • SLXN Strong Buy
  • YJ
  • Analyst Count
  • SLXN 1
  • YJ 0
  • Target Price
  • SLXN $5.00
  • YJ N/A
  • AVG Volume (30 Days)
  • SLXN 141.1K
  • YJ 52.8K
  • Earning Date
  • SLXN 08-21-2025
  • YJ 08-22-2025
  • Dividend Yield
  • SLXN N/A
  • YJ N/A
  • EPS Growth
  • SLXN N/A
  • YJ N/A
  • EPS
  • SLXN N/A
  • YJ N/A
  • Revenue
  • SLXN N/A
  • YJ $57,219,520.00
  • Revenue This Year
  • SLXN N/A
  • YJ N/A
  • Revenue Next Year
  • SLXN N/A
  • YJ N/A
  • P/E Ratio
  • SLXN N/A
  • YJ N/A
  • Revenue Growth
  • SLXN N/A
  • YJ N/A
  • 52 Week Low
  • SLXN $0.58
  • YJ $1.37
  • 52 Week High
  • SLXN $41.85
  • YJ $3.16
  • Technical
  • Relative Strength Index (RSI)
  • SLXN N/A
  • YJ 53.86
  • Support Level
  • SLXN N/A
  • YJ $1.77
  • Resistance Level
  • SLXN N/A
  • YJ $2.47
  • Average True Range (ATR)
  • SLXN 0.00
  • YJ 0.14
  • MACD
  • SLXN 0.00
  • YJ 0.00
  • Stochastic Oscillator
  • SLXN 0.00
  • YJ 25.61

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.

Share on Social Networks: